Envejecimiento
BioAging
Hospital de Sabadell
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital de Sabadell (1)
2014
-
The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: Serial observations in 37 patients
Inflammatory Bowel Diseases, Vol. 20, Núm. 4, pp. 695-702